Journey Medical Corporation DERM Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's long-term debt?
- Journey Medical Corporation (DERM) reported long-term debt of $22.87M in Q1 2026.
- How has Journey Medical Corporation's long-term debt changed year-over-year?
- Journey Medical Corporation's long-term debt decreased by 1.0% year-over-year, from $23.11M to $22.87M.
- What is the long-term trend for Journey Medical Corporation's long-term debt?
- Over 3 years (2022 to 2025), Journey Medical Corporation's long-term debt has grown at a 8.4% compound annual growth rate (CAGR), from $19.83M to $25.28M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.